Cytokinetics, Inc. and Astellas Pharma, Inc. have announced the expansion of their collaboration in skeletal muscle activators for the inclusion of amyotrophic lateral sclerosis (ALS). Read More »
Board increases to 12 members; 11 are independent directors. Read More »
Rare disease leads to severe disability; no approved therapy yet. Read More »
The U.S. Food and Drug Administration (FDA) has approved Silvergate Pharmaceuticals’ Qbrelis Oral Solution, the first Lisinopril oral solution that has been approved by the agency. Read More »
Pfizer Inc. recently published the findings from two pivotal Phase III studies of crisaborole topical ointment 2 percent, formerly known as AN2728. Read More »
Partnership makes NARCAN Nasal Spray more affordable at CVS Pharmacies. Read More »
Alerts Sign-up
